Home Site Search Learning Center Podcasts Blog Academy Resources Coaching About Login Login

Choosing the Smartest Protein Powder for Your Anticancer Smoothie: A Cancer-Type and Treatment-Phase Guide

anticancer smoothie cancer nutrition collagen peptides cancer glutamine cancer glutathione cancer heavy metals protein powder igf-1 integrative oncology nutrition keith bishop mtor plant protein cancer prevail over cancer prevail protocol protein powder cancer protein powder chemotherapy protein powder immunotherapy protein powder radiation whey protein cancer May 22, 2026

Prevail. Assess. Don't Guess.™

By Keith Bishop — Clinical Nutritionist, Cancer Coach, Retired Pharmacist, Integrative Oncology Educator, and Founder of Prevail Over Cancer LLC™ and the Prevail Protocol™

IMPORTANT — Please Read Before Using This Document

This article is for educational purposes only. It does not replace medical advice from your oncologist, physician, or licensed clinician. These statements have not been evaluated by the Food and Drug Administration. Supplements are not intended to diagnose, treat, cure, or prevent any disease.

Why the Scoop You Choose Actually Matters

A morning smoothie is one of the easiest places to load real anticancer firepower into a day — phytochemicals from berries and cruciferous sprouts, omega-3s, fiber, and protein to hold blood sugar steady and protect lean mass during treatment. But the protein powder you choose can either support the goals of an integrative oncology plan or quietly work against them.

Three filters matter most for a person navigating cancer:

  1. Growth-factor signaling — does the protein meaningfully push IGF-1 and mTOR, the same pathways many therapies are trying to quiet?
  2. Glutamate and glutamine load — does it feed pathways that aggressive tumors are known to depend on?
  3. Toxic metal contamination — does the powder itself carry lead, cadmium, arsenic, or mercury at concerning levels?

There is also a fourth conversation that deserves its own honest treatment: glutathione. Whey is famous for raising it. Whether that is a good thing during cancer treatment is more complicated than the supplement industry will tell you. We'll cover that head-on before the decision tables.

Let's walk each of the three most common protein powder categories through the three filters, address the glutathione question directly, and then land on two decision tables — one matched to your cancer type, one matched to your active treatment.

Collagen Peptides

What it is

Hydrolyzed collagen is a structural animal protein broken into small peptides, sourced from bovine hides, marine fish skin and scales, or chicken cartilage. It is roughly 30% glycine and is also rich in proline and hydroxyproline.

Benefits worth noting

  • Glycine donation. Glycine is a rate-limiting precursor for glutathione and supports gut barrier integrity and connective-tissue repair. Hydrolyzed collagen peptides are absorbed in the gastrointestinal tract and stimulate fibroblast activity, thereby increasing collagen synthesis and extracellular matrix remodeling.
  • Low impact on mTOR. Collagen is an incomplete protein. It mainly consists of glycine, proline, and hydroxyproline — it has very little leucine, the BCAA most responsible for flipping the mTORC1 switch. From a growth-factor standpoint, that is an advantage for many cancer-aware clients.
  • GI tolerance. Most people, even during chemotherapy, tolerate collagen peptides well.

Concerns

  • Not a complete protein. Collagen cannot serve as a stand-alone protein for muscle preservation during cancer cachexia. Tumor-microenvironment collagen biology is complex, and high-density tumor collagen can influence T-cell migration — this is not the same as dietary supplementation feeding tumors, but it justifies individualization.
  • Heavy metal risk in some brands. Multi-collagen blends were repeatedly flagged in independent testing; brand selection matters enormously.
  • No oncology trial evidence. There is currently no evidence that collagen supplements influence tumor collagen levels, cancer progression, or treatment response. Benefit claims for cancer outcomes are extrapolated, not proven.

Best fit: A secondary addition for skin, gut lining, and connective-tissue support — and a primary option when mTOR-quieting is the top clinical priority.

Vegan Plant Proteins (Pea, Rice, Hemp, Soy, Blends)

What it is

Isolated proteins from yellow peas, brown rice, hemp seed, soybean, or sprouted-grain blends.

Benefits worth noting

  • Lower growth-factor signaling. Plant proteins generate a softer mTOR push than whey. Ingestion of plant-based proteins induced a smaller rise in blood leucine compared to whey, which coincided with dampened mTORC1 activation, and matching the total leucine content to whey did not fully rescue the mTORC1 response. Plant proteins are inherently less mTOR-activating, by composition and digestion kinetics.
  • Fiber and polyphenols (especially hemp and pea) add modest co-benefits.
  • Dairy-free, hormone-residue-free. Avoids the milk-protein/IGF-1 conversation entirely. Persistent cow's milk protein consumption provides insulinotropic BCAAs that elevate postprandial insulin and increase hepatic IGF-1 — pivotal mTORC1 signals.

Concerns

  • The highest heavy-metal burden of the three categories. Plant-based protein powders showed three times more lead than whey-based alternatives, and chocolate-flavored powders contained four times more lead than vanilla. Plants concentrate lead, cadmium, and arsenic from soil; protein isolation concentrates them further.
  • Glutamate/glutamine content can be substantial. Soy and pea isolates carry meaningful free and bound glutamate. For tumors with glutamine-addiction phenotypes, this matters — within ovarian cancer cells, glutamine serves as the primary energy source, surpassing the metabolic rates of other amino acids, with required amounts at least 10-fold higher than those of other amino acids.
  • "Organic" is not protective for metals. Organic products averaged three times as much lead and twice as much cadmium as non-organic products. Organic farming addresses pesticides, not soil-borne metals.
  • Chocolate flavor magnifies the problem. Cocoa is itself a known concentrator of cadmium and lead.

Best fit: A primary option only when third-party tested for heavy metals, unflavored or vanilla, and ideally a pea-rice blend for a more complete amino acid profile.

Whey Protein

What it is

The liquid fraction of milk left from cheese-making is processed into concentrate (WPC), isolate (WPI), or non-denatured/bioactive forms. Grass-fed sourcing is preferred.

Benefits worth noting

  • Glutathione precursor delivery. Whey protein concentrate is rich in cystine — the disulfide-bonded form of cysteine that is more stable than free cysteine in the GI tract — making WPC an effective donor of cysteine to glutathione-depleted cells. Whether raising glutathione during active cancer treatment is a clear "win" is more nuanced than the supplement industry presents — see the section below on glutathione timing.
  • Clinical evidence in cancer patients. In a randomized, double-blind trial in cancer patients receiving chemotherapy, whey protein isolate supplementation significantly increased albumin and immunoglobulin G compared with the control, produced a significant time-dependent rise in glutathione (+11.7% vs. 6.0% in controls), and improved nutritional status scores.
  • Cleanest heavy-metal profile of the three categories. Whey and egg powders averaged about half the lead of plant-based sources.
  • Highest leucine density — the most evidence-supported protein for preserving lean mass during cancer-related weight loss and reversing cachexia.

Concerns

  • The growth-factor question is real. Milk-protein hydrolysis produces postprandial hyperinsulinemia — the insulinemic index of milk is three times higher than its glycemic index — and whey-derived amino acids are predominantly responsible. Insulin and IGF-1 synergistically activate PI3K-AKT-mTORC1 signaling. For hormone-sensitive cancers, this matters.
  • Tumor glutathione concerns (see next section). Whey is glutathione-raising, and tumors exploit elevated glutathione for chemo and radiation resistance. Timing relative to treatment matters.
  • Glutamic acid content. Whey is meaningfully glutamate-rich, which translates downstream into glutamine.
  • Quality is everything. Choose grass-fed, undenatured, non-GMO sources.

Best fit: A primary choice when preserving lean mass and reversing weight loss are the top priorities, and the cancer type is not highly hormone-sensitive or known to be glutamine-addicted, with treatment-day timing built in.

A Word on Glutathione: Timing Matters More Than the Marketing Tells You

The supplement industry has spent two decades telling cancer patients that "raising glutathione is always good." The peer-reviewed oncology literature is far more careful, and so should we be.

What's true: Glutathione (GSH) is the body's master intracellular antioxidant. It supports detoxification, immune cell function (T-cell proliferation depends on it), recovery from oxidative stress, and protection of healthy tissues. Whey delivers cysteine more efficiently than free cysteine or NAC, and clinical trials show whey can improve glutathione status, albumin, IgG, and overall nutritional resilience in cancer patients.

What's also true — and rarely said: Cancer cells run intracellular glutathione at roughly 10 mM, approximately ten times higher than normal cells. They exploit that elevated glutathione to maintain redox homeostasis, resist apoptosis, and survive treatment. Elevated GSH levels in tumor cells are associated with tumor progression and increased resistance to chemotherapeutic drugs across melanoma, hepatocarcinoma, bone marrow, breast, colon, pancreatic, and lung cancers. High GSH is independently associated with resistance to chemotherapy and radiation; on the other hand, GSH depletion can improve the susceptibility of cancer cells to various forms of programmed cell death.

A 2024 propensity-matched study of 460 breast cancer patients found that excessive glutathione intake contributed to chemotherapy resistance. Cervical cancer radiotherapy response correlates with how much tumor GSH drops with treatment. And many chemotherapy drugs — anthracyclines like doxorubicin, alkylators like cyclophosphamide, platinums like cisplatin — work specifically by generating reactive oxygen species. Loading antioxidants upstream of those drugs can blunt their mechanisms of action.

So what does this mean practically?

Glutathione support is biphasic and timing-dependent in active cancer care. It is not "always good" or "always bad." It is good in the right window and counterproductive in the wrong one.

Most defensible timing for whey and glutathione-raising support:

  • Between chemotherapy cycles, for nutritional recovery, albumin rebuilding, and immune restoration
  • Throughout immunotherapy (T-cells need GSH to proliferate and attack tumors; checkpoint inhibitors do not depend on ROS to kill cancer cells)
  • Surgical prehabilitation and post-operative recovery
  • Cachexia and active lean-mass loss (the cachexia threat usually outweighs the GSH-resistance concern)
  • Long-term survivorship and post-treatment recovery

Most cautious timing:

  • On infusion days with ROS-generating chemo (doxorubicin, epirubicin, cisplatin, carboplatin, cyclophosphamide)
  • During daily radiation fractions, especially in tumors already known for radioresistance (cervix, ovarian, glioblastoma)
  • In tumors with documented high baseline GSH (melanoma, hepatocellular carcinoma, advanced breast, colon, pancreatic, lung)

Practical rule of thumb: A common integrative approach is to skip whey (and other antioxidant-loading supplements) the day before, day of, and day after an infusion or radiation fraction — and to use it freely between treatments for recovery and nutritional support. This is the same 3-day skip window many integrative oncology practitioners use for repurposed medications and therapeutic herbs around chemotherapy.

This is exactly the kind of decision that benefits from working with an integrative oncology clinician — your tumor type, drug regimen, and goals all shape the right answer.

Table 1 — Best Protein Powder by Cancer Type

Cancer Type Primary Protein Secondary Add-In Avoid or Minimize Why
Prostate (hormone-sensitive, ADT) Plant blend (pea + rice, vanilla, tested) Collagen peptides Whey Strong IGF-1/mTOR concerns from dairy proteins; lower-signal plant + collagen is cleaner
Breast (ER+/PR+, HER2+) Plant blend (pea + rice, tested) Collagen peptides Whey, soy isolate (ER+) Hormone-axis sensitivity; soy isolate controversial in ER+; whey raises insulin/IGF-1
Breast (triple-negative) Plant blend or modest grass-fed whey (tested) Collagen peptides Excessive whey (GSH/chemo-resistance concern) Aggressive subtype; lean mass priority — but mind glutathione timing with chemo
Ovarian Collagen-forward + small amount clean whey Pea-rice in small amounts Soy isolate, high-glutamate plant blends Documented glutamine addiction; high tumor GSH common — be careful with whey timing
Pancreatic (PDAC) Collagen-forward + small amount clean whey Pea-rice if tolerated Soy isolate, high-glutamate plant blends KRAS-mutant glutamine dependency; cachexia risk also demands some complete protein
Colorectal Grass-fed whey isolate (tested) Collagen peptides Chocolate-flavored powders Cachexia common; gut-lining support from collagen glycine — time whey away from infusions
Lung (NSCLC, SCLC) Grass-fed whey isolate (tested) Collagen peptides High-metal plant powders Cachexia is the bigger threat — whey reverses weight loss in lung cancer on chemo/radiation
Lymphoma (Hodgkin's, NHL) Grass-fed whey isolate (tested) Collagen peptides Cheap commercial whey Lean mass preservation through long cycles; time around infusion days
Leukemia (AML, ALL, CLL) Grass-fed whey isolate (tested) Collagen peptides High-metal/unverified plant powders Lean mass + immune support priority; clean sourcing critical due to immunocompromise
Brain (glioblastoma, gliomas) Collagen-forward Small amounts of pea-rice or clean whey High-glutamate sources, MSG, soy isolate Glutamate → glutamine fuels glioma metabolism; high GSH = radioresistance
Head & neck (HNSCC, OSCC) Grass-fed whey isolate (tested) Collagen peptides Anything irritating to the mucosa Mucositis risk; cachexia common — time whey away from radiation fractions
Bladder / kidney /
renal cell		 Grass-fed whey isolate (tested) Collagen peptides Soy isolate, high-glutamate plant blends Some urogenital cancer evidence for whey; renal patients need clinician-set protein totals
Liver (HCC) Plant blend (pea + rice, tested) — low total dose Collagen peptides Whey at high amounts Protein totals must be clinician-set; HCC has a high baseline GSH — be very cautious with whey
Sarcoma (soft tissue, liposarcoma) Grass-fed whey isolate (tested) Collagen peptides High-metal plant powders Lean mass through aggressive treatment; time around infusion days
Endometrial / uterine Plant blend (pea + rice, tested) Collagen peptides Whey at high amounts Often hormone-influenced; lower IGF-1/mTOR push preferred
Skin (melanoma) Grass-fed whey isolate (tested) — careful timing Collagen peptides Whey during ROS-based chemo Immunotherapy is standard of care (whey helpful here) — but melanoma has high baseline GSH
Thyroid Plant blend (pea + rice, tested) Collagen peptides Soy isolate Soy isoflavones are controversial in thyroid; a clean plant blend is cleaner by default
Cervical Grass-fed whey isolate (tested) Collagen peptides Whey during daily radiation fractions Cervical radiation response correlates with tumor GSH drop — strict timing around RT
Active cachexia / weight loss (any cancer) Grass-fed whey isolate (tested) Collagen peptides Anything worsening GI tolerance Lean mass preservation overrides GSH concern — cachexia is the bigger threat to outcomes
Remission / surveillance (any cancer) Rotate plant blend + collagen + occasional clean whey All three categories Single-source overuse Variety reduces concentration risk; lower baseline mTOR push in remission is reasonable

Table 2 — Best Protein Powder by Treatment Type

Treatment Primary Protein Secondary Add-In Timing Note Why
Chemotherapy — ROS-generating drugs (doxorubicin, epirubicin, cisplatin, carboplatin, cyclophosphamide) Grass-fed whey between cycles; collagen + pea-rice around infusion days Collagen peptides Skip whey on the day before, the day of, and the day after infusion. Use freely between cycles for recovery These drugs kill via ROS — loading glutathione precursors on infusion days can blunt the mechanism; use for recovery, not concurrent
Chemotherapy — low-ROS drugs (antifolates, nucleoside/nucleotide analogs) Grass-fed whey isolate (tested) Collagen peptides Daily, more flexible timing Lower ROS-interference concern; whey's GSH-support + nutritional benefits dominate
Chemotherapy — glutamine-addicted tumors (ovarian, pancreatic, MYC/KRAS-driven) Collagen peptides + small amount clean whey Pea-rice if tolerated Smaller, more frequent servings; skip whey around infusions Avoid front-loading glutamate/glutamine while targeting the same metabolic pathway
Immunotherapy — checkpoint inhibitors (anti-PD-1, anti-PD-L1, anti-CTLA-4) Grass-fed whey isolate (tested) Collagen peptides Daily, consistent use Checkpoint inhibitors do not depend on ROS to kill cancer; T-cells require glutathione to proliferate and attack — net benefit is clearest here
CAR-T cell therapy Grass-fed whey isolate (tested) Collagen peptides Daily under clinician guidance Same T-cell-GSH rationale; nutrition status closely watched pre and post infusion
Radiation therapy Grass-fed whey for nutritional support; collagen + plant blend on RT days Collagen peptides Skip whey on radiation days; use generously on rest days and after the RT course Radiation works via ROS; tumor GSH protects against radiation. Time whey away from fractions, use heavily for recovery
Radiation to the head & neck or the GI tract Whichever the patient tolerates — texture matters Collagen peptides Smaller, more frequent volumes for mucositis; whey timing as above Mucositis demands soft, bland; tolerance can override theoretical timing concerns
Hormone therapy (ADT, tamoxifen, aromatase inhibitors) Plant blend (pea + rice, tested) Collagen peptides Daily Minimizing IGF-1/mTOR signaling aligns with the therapeutic goal
Targeted therapy — TKIs, mTOR inhibitors (everolimus, sirolimus) Plant blend (pea + rice, tested) Collagen peptides Daily Do not stack mTOR-stimulating dietary inputs against an mTOR-inhibiting drug
Surgery — pre-op (prehab) Grass-fed whey isolate (tested) Collagen peptides Daily for 2–4 weeks pre-op Maximize lean mass and glutathione before surgical oxidative stress
Surgery — post-op (recovery) Grass-fed whey isolate (tested) Collagen peptides Daily through wound-healing window Glycine + leucine support wound repair and lean-mass recovery; no chemo/RT timing conflict here
Stem cell / bone marrow transplant Clinician-directed (often whey) Collagen peptides Strict food-safety protocols; clinician-guided Neutropenic precautions and immune fragility demand individualized planning — do not self-prescribe
Active monitoring / watchful waiting Rotate plant blend + collagen + occasional clean whey All three acceptable Variety over consistency Lower baseline mTOR push is reasonable; rotate to reduce concentration risk
Survivorship / surveillance Rotate plant blend + collagen + occasional clean whey All three acceptable Variety over consistency Same rationale; whey acceptable for lean mass maintenance once treatment is complete

The Three-Filter Summary

Filter Collagen Peptides Vegan Plant Proteins Whey Protein
Growth factors (IGF-1, mTOR) ✅ Lowest signal — minimal leucine ✅ Lower than whey, even leucine-matched ⚠️ Highest postprandial insulin/IGF-1 push
Glutamate / Glutamine load ✅ Low (glycine-dominant) ⚠️ Moderate to high (especially soy, pea) ⚠️ High
Toxic metal contamination ⚠️ Variable — some multi-collagen blends flagged 🚫 Highest of the three categories ✅ Cleanest of the three categories
Glutathione support ➖ Indirect (glycine donor) — gentle, less timing-sensitive ➖ Limited ⚠️ Strong direct (cysteine/cystine donor) — requires treatment-day timing
Complete protein for lean mass 🚫 No ✅ Yes (especially pea-rice blends) ✅ Yes (highest leucine density)

Non-Negotiable Rules Regardless of Which You Choose

  1. Buy third-party tested for heavy metals. Look for Clean Label Project certification, NSF, or Informed Choice. In Consumer Reports testing, about 70 percent of products exceeded their lead concern level.
  2. Skip the chocolate flavor. Vanilla or unflavored only.
  3. Skip "organic" as a proxy for clean. It addresses pesticides, not metals.
  4. No artificial sweeteners, no seed oils, no synthetic additives.
  5. Match the protein to the cancer biology, the treatment phase, and the treatment day — not to the loudest marketing claim.

The Anticancer Smoothie Frame

Whatever protein scoop you select, build the rest of the smoothie around it:

  • Cruciferous sprouts (broccoli, kale) for sulforaphane
  • Berries (low-glycemic, polyphenol-rich)
  • Ground flax or chia for fiber and lignans
  • A green (organic baby spinach, kale)
  • Fat to slow absorption (avocado, MCT, or a small amount of nut butter)
  • An unsweetened base (filtered water, unsweetened almond, or organic coconut milk)

That combination keeps insulin and IGF-1 spikes blunted, layers in real anticancer phytochemistry, and lets your protein choice serve its job rather than work against you.

POC Resources for Going Deeper

For deeper, personalized integrative oncology guidance built on the Prevail Protocol™ framework:

Together — We Prevail Over Cancer!™

Prevail. Assess. Don't Guess.™

About the Author

 

Written and researched by Keith Bishop — Clinical Nutritionist, Cancer Coach, Retired Pharmacist, Integrative Oncology Educator, and Founder of Prevail Over Cancer LLC™ and the Prevail Protocol™. Keith combines decades of pharmacology experience with evidence-based integrative oncology to help you and your loved ones make informed decisions about nutrition, supplements, and lifestyle at every phase of cancer care. Since 1999, Keith has helped thousands of people navigate cancer with clarity, strategy, and hope.

Learn more about Keith →

References

  1. Teixeira FJ, Santos HO, Howell SL, Pimentel GD. Whey protein in cancer therapy: A narrative review. Pharmacol Res. 2019;144:245-256. PMID: 31022531. PubMed
  2. Bumrungpert A, Pavadhgul P, Nunthanawanich P, Sirikanchanarod A, Adulbhan A. Whey Protein Supplementation Improves Nutritional Status, Glutathione Levels, and Immune Function in Cancer Patients: A Randomized, Double-Blind Controlled Trial. J Med Food. 2018;21(6):612-616. PMID: 29565716. PubMed
  3. Kennedy RS, Konok GP, Bounous G, Baruchel S, Lee TD. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study. Anticancer Res. 1995;15(6B):2643-2649. PMID: 8669840. PubMed
  4. Tozer RG, Tai P, Falconer W, et al. Cysteine-rich protein reverses weight loss in lung cancer patients receiving chemotherapy or radiotherapy. Antioxid Redox Signal. 2008;10(2):395-402. PMID: 17961075. PubMed
  5. Traverso N, Ricciarelli R, Nitti M, et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2013;2013:972913. PMID: 23766865. PubMed
  6. Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;217(7):2291-2298. PMID: 29844011. PubMed
  7. Kennedy L, Sandhu JK, Harper ME, Cuperlovic-Culf M. Role of Glutathione in Cancer: From Mechanisms to Therapies. Biomolecules. 2020;10(10):1429. PMID: 33050144. PubMed
  8. Liu Y, et al. Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis. 2024. PMID: 39709415. PubMed
  9. Bhattathiri VN, Bindu L, Remani P, et al. Possible role of glutathione in predicting radiotherapy response of cervix cancer. Int J Radiat Oncol Biol Phys. 1999;43(1):155-158. PMID: 9989523. PubMed
  10. Woldeselassie M, Tamene A. Therapeutic controversies over use of antioxidant supplements during cancer treatment: a scoping review. Front Nutr. 2024;11:1480780. PMID: 39698244. PubMed
  11. Melnik BC, John SM, Schmitz G. The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer. Nutr Metab (Lond). 2012;9:74. PMID: 22853725. PubMed
  12. Melnik BC. Lifetime Impact of Cow's Milk on Overactivation of mTORC1. Biomolecules. 2021;11(3):404. PMID: 33803410. PubMed
  13. van Vliet S, Burd NA, van Loon LJ. The Skeletal Muscle Anabolic Response to Plant- versus Animal-Based Protein Consumption. J Nutr. 2015;145(9):1981-1991. PMID: 26224750. PubMed
  14. Vinet R, Cortés M, Álvarez R, et al. Dampened Muscle mTORC1 Response Following Ingestion of High-Quality Plant-Based Protein and Insect Protein Compared to Whey. Nutrients. 2021;13(5):1396. PMID: 33919054. PubMed
  15. Yang L, Venneti S, Nagrath D. Glutaminolysis: A Hallmark of Cancer Metabolism. Annu Rev Biomed Eng. 2017;19:163-194. PMID: 28301735. PubMed
  16. Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer. 2016;16(10):619-634. PMID: 27492215. PubMed
  17. Memorial Sloan Kettering Cancer Center. Collagen — Integrative Medicine. Updated 2025. MSKCC
  18. Bandyopadhyay S, et al. A human health risk assessment of heavy metal ingestion among consumers of protein powder supplements. Toxicol Rep. 2020;7:1255-1262. PMID: 33005570. PubMed
  19. Clean Label Project. Protein Study 2.0. Published January 2025. Clean Label Project

© 2026 Keith Bishop — Prevail Over Cancer LLC. All rights reserved.

prevailovercancer.com

Author

Keith Bishop

Clinical Nutritionist, Cancer Coach, Retired Pharmacist, Author

Keith Bishop founded Prevail Over Cancer and is a passionate advocate for cancer awareness and research. With a background in pharmacy and clinical nutrition I’m dedicated to providing insightful and empowering information to help clients, survivors, and caregivers navigate their journey. From personal experiences and a commitment to holistic health, Keith aims to inspire and support the cancer community through comprehensive and accessible content.

Join over 8,000 subscribers! 
Get access to Keith's Prevail Over Cancer Newsletter with news, blogs, and updates!
Get Access!
Close

Get Free Access to Keith’s Sunday Tactics Newsletter.

Join thousands of subscribers!
Get new cancer tactics each week.